arterial hypertension (HTA) It continues to be one of the main worldwide cardiovascular risk factors, affecting millions of people and representing a significant cause of adverse events such as myocardial infarction, stroke and renal damage. In the search to optimize the control of this condition, las…

Los ensayos clínicos aleatorizados controlados han demostrado una reducción de la insuficiencia cardíaca (IC) of the 50% o más con el tratamiento antihipertensivo1. Los mecanismos para la prevención de la IC se explican por la prevención del infarto al miocardio, la prevención y regresión de la hipertrofia ventricular izquierda (HVI) durante…

In December 2023 The European Hypertension Society published an extensive guide to help clinicians to diagnose, Stratify and treat this condition. It is unquestionable that the document has constituted a valuable contribution in this field. However, un aspecto que se ha prestado para la controversia ha…